4-Bromo-3-chloropicolinamide

Catalog No.: 
ACLPYW731
CAS No.: 
1805017-96-2
Molecular Formula: 
C6H4BrClN2O
Molecular Weight: 
235.47
4-Bromo-3-chloropicolinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$313.00InquiryInquiry
1g95%$955.00InquiryInquiry
5g95%$4727.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-3-chloropicolinamide
IUPAC Name4-bromo-3-chloropicolinamide
Molecular FormulaC6H4BrClN2O
Molecular Weight235.47
SMILESO=C(N)C1=NC=CC(Br)=C1Cl
InChI KeyDDHHHLIXCHYTRH-UHFFFAOYSA-N
Synonym2-Pyridinecarboxamide, 4-bromo-3-chloro-
CAS No.1805017-96-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLPYW731 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACLPYW731 route product structure diagram
    ACLPYW7311805017-96-2
Inquiry

2. ACLPYW731 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLPYW731 route product structure diagram
    ACLPYW7311805017-96-2
Inquiry

3. ACLPYW731 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACLPYW731 route product structure diagram
    ACLPYW7311805017-96-2
Inquiry

Comments (0)